U.S., Aug. 6 -- An application to own the trademark for 'RAXMYTO' has been filed on Apr. 29, 2025.
Owner(s):
CHIESI FARMACEUTICI S.P.A.; Via Palermo 26 A, , ITALY
Goods and/or Services:
For: Pharmaceutical preparations for the treatment of muscular dystrophy, muscle wasting, atrophy, neuromuscular diseases, cardiomyopathies, ataxias, optic nerve degradation, neurological indications and memory loss
Class(es): 005, 006, 018, 044, 046, 051, 052
Mark Drawing Type: 4 - STANDARD CHARACTER MARK
https://eog-tmng.uspto.gov/#/issueDate=2025-08-05&serialNumber=99161266
Disclaimer: Curated by HT Syndication....